Cancer Family

Breast Neoplasm

Non-malignant2,894 active trials43 approved drugs310 evidence items

NCIt: C2910
OncoTree: BNNOS
MeSH: D000069584
MeSH: D001943

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (268)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 268 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Breast cancer active unsymmetrical diamine and sulfur chelator-based Pd(II) complexes: Their bio-activity, cytotoxicity and photo-physical properties.
Sharmistha Chatterjee, Sankar Chandra Moi · J Inorg Biochem · Dec 1, 2026 · PMID 42648073 · candidate dictionary pubmed
DCE-MRI and Mammography integrated radiomic analysis in triple negative ductal invasive breast cancer patients. Comparison between BRCA and not BRCA mutated patients: preliminary results.
Annarita Pecchi, Cecilia Beretta, Erica Balboni et al. · Eur J Radiol Open · Dec 1, 2026 · PMID 42750703 · candidate dictionary pubmed
Targeting an ASCL1-WNT11-ERK feed-forward loop to overcome pyrotinib resistance in HER2-positive breast cancer.
Fang Yin, Boxuan Zhou, Yingliang Li et al. · Mater Today Bio · Dec 1, 2026 · PMID 42787995 · candidate dictionary pubmed
Engineered nanodendritic sonosensitizers empower sonodynamic-elicited ferroptosis and PANoptosis against platinum-resistant breast cancer.
Jiahui Chen, Yu Shen, Yi Zheng et al. · Mater Today Bio · Dec 1, 2026 · PMID 42787986 · candidate dictionary pubmed
Breast cancer and diabetes mellitus-related mortality among U.S. adults: a 25-year CDC WONDER analysis (1999-2023).
Mifrah Rahat Khan Sherwani, Filza Rahat Khan, Youssef Ramadan et al. · J Diabetes Metab Disord · Dec 1, 2026 · PMID 42787511 · candidate dictionary pubmed
Prognostic value of ZEB1 and its association with miR-7641 in triple-negative breast cancer: a correlative and in vitro study.
Wentian Zheng, Dongxing Xu, Huan Yang · J Obstet Gynaecol · Dec 1, 2026 · PMID 42782076 · candidate

dictionary

pubmed

New insights into breast cancer therapy: application and mechanisms of novel targeted nano-formulation.

Rui-Chao Li, Ze-Yuan Sun, Si-Nian Li et al. · Int J Pharm X · Dec 1, 2026 · PMID 42781505 · candidate dictionary pubmed

Breast cancer recurrence: socioeconomic position and general practice involvement - a nationwide cohort study in Denmark.

Anna Colding Godsk, Kasper Grooss, Linda Aagaard Rasmussen et al. · Scand J Prim Health Care · Dec 1, 2026 · PMID 42776143 · candidate dictionary pubmed

Molecular insights into triazole-based compounds for triple-negative breast cancer treatment.

Ahamed Vilangalil, Sindhu Priya E S, Sarad Pawar Naik Bukke et al. · J Enzyme Inhib Med Chem · Dec 1, 2026 · PMID 42803315 · candidate dictionary pubmed

Re: "Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer".

Sixten Harborg, Signe Borgquist, Deirdre Cronin-Fenton · Epidemiology · Nov 1, 2026 · PMID 42555912 · candidate dictionary pubmed

Re: Survival and "Recurrence With GLP-1 Receptor Agonists in Breast Cancer".

Maret L Maliniak, Julie Barberio, Rebecca Nash et al. · Epidemiology · Nov 1, 2026 · PMID 42555906 · candidate dictionary pubmed

The role of radiation therapy in leptomeningeal disease from breast cancer - a multicenter analysis.

Felix Ehret, Audrey Aitelli, Andrzej Niemierko et al. · Clin Transl Radiat Oncol · Nov 1, 2026 · PMID 42699679 · candidate dictionary pubmed

[Retracted] MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.

Jing Wu, Zhihui Sun, Huijie Sun et al. · Mol Med Rep · Nov 1, 2026 · PMID 42695419 · candidate dictionary pubmed

The impact of effective dose to the immune cells on survival in breast cancer patients.

Stefanie A de Boer, Daan S Spoor, John H Maduro et al. · Clin Transl Radiat Oncol · Nov 1, 2026 · PMID 42662902 · candidate dictionary pubmed

ACOD1 enhances the ferroptosis resistance of tumor-associated macrophages through the KEAP1/NRF2 axis and promotes triple-negative breast cancer progression.

Jie Yang, Xiyin Li, Xin Qu et al. · Pathol Res Pract · Nov 1, 2026 · PMID 42617477 · candidate dictionary pubmed

Artificial intelligence-supported double reading in European population breast cancer screening: A systematic review and meta-analysis of prospective programs.

Romuald Ferre, Thad Benefield, Cherie M Kuzmiak · Clin Imaging · Nov 1, 2026 · PMID 42617468 · candidate dictionary pubmed

Advancing equitable breast cancer screening: the role of patient-centered education, community outreach, and accessible care pathways.

Shalinie Mahadeo, Katerina Dodelzon, Marina Corines · Clin Imaging · Nov 1, 2026 · PMID 42617467 · candidate dictionary pubmed

Cationic amino acid-engineered radiopeptides for breast cancer targeting.

Akanksha Jain, Manoj Kumar, R Vasumathy et al. · Bioorg Med Chem · Nov 1, 2026 · PMID 42612457 · candidate dictionary pubmed

Early adoption and perceived clinical impact of breast cancer detection artificial intelligence tools: Survey of society of breast imaging radiologists.

Joud Almogati, Khang Tong, Tara Retson et al. · Clin Imaging · Nov 1, 2026 · PMID 42607357 · candidate dictionary pubmed

A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening tools.

Liliana Light, Miguel Pena, Sarah M Pittman et al. · Clin Imaging · Nov 1, 2026 · PMID 42607355 · candidate dictionary pubmed

Design, synthesis, and biological evaluation of selective estrogen receptor modulators (SERMs) as anticancer agents for ER-positive breast cancer.

Anurag Saini, C Mythri, Ripunjay Kalita et al. · Bioorg Med Chem · Nov 1, 2026 · PMID 42585901 · candidate dictionary pubmed

Clinicopathological characteristics and potential impact of previous treatment history in metachronous contralateral breast cancer: Insights from a real-world retrospective study.

Ritsuko Sasaki, Koji Yamamoto, Kotaro Iijima et al. · Oncol Lett · Nov 1, 2026 · PMID 42756975 · candidate dictionary pubmed

[Expression of Concern] MicroRNA‑195‑5p is a potential diagnostic and therapeutic target for breast cancer.

Qifeng Luo, Chuankui Wei, Xiaoyu Li et al. · Oncol Rep · Nov 1, 2026 · PMID 42788358 · candidate dictionary pubmed

Postoperative complications of breast risk-reduction surgery in very high risk breast cancer patients: A series of 253 cases.

Juliette Fraisse, Charline Berthier, Charlotte Vaysse et al. · JPRAS Open · Nov 1, 2026 · PMID 42780932 · candidate dictionary pubmed

From molecular to microenvironmental reprogramming: Multi-target strategies of flavonoids to overcome paclitaxel resistance in triple-negative breast cancer.

Meiling Zhang, Yuan Chang, Jingyu Shen et al. · Phytomedicine · Nov 1, 2026 · PMID 42715878 · candidate dictionary pubmed